🌍·3d agoIndustry
AbelZeta Receives EMA PRIME Designation for C-CAR168 in Lupus Nephritis and Systemic Lupus Erythematosus
Publisher
A
AbelZeta Pharma
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- AbelZeta Pharma
- Region
- Global
- Scope
- Industry
- Published
- July 20, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on abelzeta.com
Leave the platform to read the original full article on the publisher site.
Source: AbelZeta Pharma
Scope: Industry
Related coverage
More related coverage
Codexis/9h ago
Codexis Announces Pricing of Public Offering of Common Stock
Aspen Pharmacare/1h ago
Strengthening partnerships, visibility and sustainable progress in the CDMO space
Nippon Shinyaku News/1h ago
「第97回 都市対抗野球大会」組み合わせ決定 日本新薬は鹿嶋市代表「日本製鉄鹿島」と対戦
Merck & Co. (MSD) News/2h ago